Abstract
The adenomatous polyposis coli (APC) gene has been shown to be involved in genetic instability and to be downregluated in several human carcinomas. The chromosome locus of APC, 5q21-22, is frequently deleted in colorectal cancers (CRCs). The functional impact of such regions needs to be extensively investigated in large amount of clinical samples. Case-matched tissues of CRC and adjacent normal epithelium (n = 134) were included in this study. Quantitative PCR was carried out to examine the copy number as well as mRNA expression of APC gene in colorectal malignancies. Our results showed that copy number deletions of APC were present in a relatively high percentage of colorectal cancer samples (26.1%, 35 out of 134). There was a positive correlation between copy number decrease of APC and tumor progression in CRCs. Furthermore, copy number loss of APC was correlated with decreased mRNA expression. However, mRNA levels of APC were also impaired in CRC samples with unaltered copy numbers, indicating that sporadic CRCs exhibit different mechanisms of APC regulation.
Similar content being viewed by others
References
Munemitsu S, Souza B, Muller O et al (1994) The apc gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 54:3676–3681
Henderson BR (2000) Nuclear-cytoplasmic shuttling of apc regulates beta-catenin subcellular localization and turnover. Nat Cell Biol 2:653–660
Neufeld KL, Nix DA, Bogerd H et al (2000) Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc Natl Acad Sci USA 97:12085–12090
Wong MH, Hermiston ML, Syder AJ et al (1996) Forced expression of the tumor suppressor adenomatosis polyposis coli protein induces disordered cell migration in the intestinal epithelium. Proc Natl Acad Sci USA 93:9588–9593
Narayan S, Roy D (2003) Role of apc and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer 2:41
Smith KJ, Levy DB, Maupin P et al (1994) Wild-type but not mutant apc associates with the microtubule cytoskeleton. Cancer Res 54:3672–3675
Barth AI, Pollack AL, Altschuler Y et al (1997) Nh2-terminal deletion of beta-catenin results in stable colocalization of mutant beta-catenin with adenomatous polyposis coli protein and altered mdck cell adhesion. J Cell Biol 136:693–706
Goss KH, Groden J (2000) Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol 18:1967–1979
Fearnhead NS, Britton MP, Bodmer WF (2001) The abc of apc. Hum Mol Genet 10:721–733
Gumbiner BM (1997) Carcinogenesis: a balance between beta-catenin and apc. Curr Biol 7:R443–R446
McCartney BM, Nathke IS (2008) Cell regulation by the apc protein apc as master regulator of epithelia. Curr Opin Cell Biol 20:186–193
Huang J, Zheng S, Jin S (1996) apc mutation analysis in sporadic colorectal cancer. Zhonghua Zhong Liu Za Zhi 18:415–418
Ruiz-Ponte C, Vega A, Carracedo A et al (2001) Mutation analysis of the adenomatous polyposis coli (apc) gene in northwest spanish patients with familial adenomatous polyposis (fap) and sporadic colorectal cancer. Hum Mutat 18:355
Lichtenstein P, Holm NV, Verkasalo PK et al (2000) Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85
Chung DC (2000) The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis. Gastroenterology 119:854–865
Camps J, Armengol G, del Rey J et al (2006) Genome-wide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis 27:419–428
Knosel T, Petersen S, Schwabe H et al (2002) Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases. Virchows Arch 440:187–194
Ueno K, Kumagai T, Kijima T et al (1998) Cloning and tissue expression of cdnas from chromosome 5q21-22 which is frequently deleted in advanced lung cancer. Hum Genet 102:63–68
Redon R, Ishikawa S, Fitch KR et al (2006) Global variation in copy number in the human genome. Nature 444:444–454
Oreffo VI, Robinson S, You M et al (1998) Decreased expression of the adenomatous polyposis coli (apc) and mutated in colorectal cancer (mcc) genes in mouse lung neoplasia. Mol Carcinog 21:37–49
Bodmer WF, Cottrell S, Frischauf AM et al (1989) Genetic analysis of colorectal cancer. Princess Takamatsu Symp 20:49–59
Luo L, Shen GQ, Stiffler KA et al (2006) Loss of heterozygosity in human aberrant crypt foci (acf), a putative precursor of colon cancer. Carcinogenesis 27:1153–1159
Dermitzakis ET, Stranger BE (2006) Genetic variation in human gene expression. Mamm Genome 17:503–508
Reymond A, Henrichsen CN, Harewood L et al (2007) Side effects of genome structural changes. Curr Opin Genet Dev 17:381–386
Jass JR, Barker M, Fraser L et al (2003) Apc mutation and tumour budding in colorectal cancer. J Clin Pathol 56:69–73
Ostwald C, Linnebacher M, Weirich V et al (2009) Chromosomally and microsatellite stable colorectal carcinomas without the cpg island methylator phenotype in a molecular classification. Int J Oncol 35:321–327
Acknowledgements
This work was supported by National Natural Science Foundation of China (81001173 /H1622).
Author information
Authors and Affiliations
Corresponding author
Additional information
Grant Sponsor: National Natural Science Foundation of China (81001173/H1622)
Electronic supplementary materials
Below is the link to the electronic supplementary material.
Fig. S1
The representative diagram of the DNA CNV analysis for one cancer/ANT pair. (A) Real-time PCR amplification of targeted gene in selected genomic DNA samples. Each data was obtained from two independent reactions. (B) Original Ct values obtained from the real-time PCR amplification. (C&D) The efficiency of and slope of the RNAse P and APC amplification were calculated by Bio-Rad Thermal Cyclers software. The detailed calculation was performed as follow: dCt = average Ct (APC)-average Ct (RNAse P); ddCt (sample1) = dCt (CRC)- dCT (ANT) = 2.96; Etarget was determined by the efficiency of target gene amplification. Cut-off value (sample1) = E−ddCt = 2.05−2.96 = 0.12. The copy number of APC in sample1 is 0. (GIF 24 kb)
Fig. S2
The representative diagram of the calculation of mRNA expression for one cancer/ANT pair. (A) Real-time PCR amplification of targeted gene in selected cDNA samples. Each data was obtained from two independent reactions. (B) Original Ct values obtained from the real-time PCR amplification. (C&D) The efficiency of and slope of the GAPDH and APC amplification were calculated by Bio-Rad Thermal Cyclers software. 2−∆Ct method was used to calculate the obtained results, and the mRNA level of APC was expressed as a ratio relative to the GAPDH mRNA in each sample. For this sample: ∆Ct (CRC) = average Ct (APCCRC)-average Ct (GAPDHCRC) =5.59; ratio (CRC) = 2−∆Ct(CRC) = 0.021 = 2.1%; ∆Ct (ANT) = average Ct (APCANT)-average Ct (GAPDHANT) =2.88; ratio (ANT) =2−∆Ct(ANT) =0.136 = 13.6%. (GIF 24 kb)
Rights and permissions
About this article
Cite this article
Fang, Z., Xiong, Y., Li, J. et al. Detection of APC Gene Deletions in Colorectal Malignancies Using Quantitative PCR in a Chinese Population. Pathol. Oncol. Res. 17, 657–661 (2011). https://doi.org/10.1007/s12253-010-9359-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-010-9359-2